Please login to the form below

Not currently logged in

black box warning

This page shows the latest black box warning news and features for those working in and with pharma, biotech and healthcare.

FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz

FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz

In 2019, the FDA released a formal warning in response to initial results that showed an increased risk of blood clots and death with the higher dose. ... At that time, the US drugs regulator issued a black box warning to the prescribing information for

Latest news

More from news
Approximately 1 fully matching, plus 53 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...